Role of Natural Light in the Prevention of Delirium After Cardiac Surgery: a Prospective Observational Study With Historical Control
NCT ID: NCT05936944
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
448 participants
OBSERVATIONAL
2023-06-14
2024-06-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be an observational prospective study with historical control (pre/post-study) whose primary objective is to identify the incidence of postoperative delirium in patients undergoing cardiac surgery. The population will be adult patients undergoing cardiac surgery at our University Hospital over a period of 12 months. The intervention will be exposure to totally artificial light (for patients hospitalized after the relocation of the department to its original location). The comparator will be exposure to natural light (for patients who will be hospitalized during our temporary transfer to an environment with natural lighting). The outcome will be the incidence of delirium, measured with the Confusion Assessment Method-Intensive Care Unit (CAM-ICU) scale; episodes of agitation requiring sedative drugs; time elapsed before onset of delirium. The study will last 12 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated Pupillometry in Patients Underwent Cardiac Surgery to Predict Postoperative Delirium
NCT06255132
Predictive Factors and Complications of Delirium
NCT03246165
Projection of Visual Material on Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT05932394
Post-surgical Delirium in Patients Undergoing Open Heart Surgery.
NCT03806413
Cognitive Training for the Prevention of Postoperative Delirium
NCT02963961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Natural Light
Group of patients enrolled in the first ICU, with natural lighting
No interventions assigned to this group
Artificial Light
Group of patients enrolled in the second ICU, with totally artificial lighting
Exposure to totally artificial lighting
The second group of patients will be admitted to an ICU without windows and with a totally artificial lighting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure to totally artificial lighting
The second group of patients will be admitted to an ICU without windows and with a totally artificial lighting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* planned ICU admission after surgery
Exclusion Criteria
* patient with diagnosed dementia or major depressive disorder
* patient unable to perform CAM-ICU evaluation
* emergent surgery
* patient in ICU before surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero-Universitaria di Parma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davide Nicolotti
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale Maggiore di Parma
Parma, PR, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIRER 6097
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.